(Q41717109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

The molecular and cellular pathophysiology of heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

M Bondmass

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D W Schwertz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

3-19; quiz 20-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

Diastolic Dysfunction in Congestive Heart Failure

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Congestive heart failure with normal systolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Changing epidemiological features of cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Regulation of renin synthesis in the juxtaglomerular cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

An enzyme in human blood plasma that inactivates bradykinin and kallidins

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Cardiac hypertrophy. Mechanical, neural, and endocrine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Basic mechanisms in heart failure: the cytokine hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Cytokines and their receptor complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Vesnarinone: a new inotropic agent for treating congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Increased plasma concentrations of endothelin in congestive heart failure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Increased endothelin in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Endothelin in human congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Integrated cardiac, renal, and endocrine actions of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Endothelin is a positive inotropic agent in human and rat heart in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Atrial natriuretic peptide: its mechanism of release from the atrium

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Atrial natriuretic factor: physiologic actions and implications in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Cardiac hypertrophy: Its characteristics as a growth process

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Wall stress and patterns of hypertrophy in the human left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Quantitative changes in the capillary bed during developing, peak, and stabilized cardiac hypertrophy in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Myosin isoenzyme redistribution in chronic heart overload

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alpha-skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Myosin isoenzymes in normal and hypertrophied human ventricular myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Myosin isoenzymic distribution correlates with speed of myocardial contraction

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Endomyocardial gene expression during development of pacing tachycardia-induced heart failure in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alteration of Ca2+ release channel function in sarcoplasmic reticulum of pressure-overload-induced hypertrophic rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The density of ryanodine receptors decreases with pressure overload-induced rat cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Differential regulation of two types of intracellular calcium release channels during end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Rat cardiac hypertrophy. Altered sodium-calcium exchange activity in sarcolemmal vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alterations in calcium antagonist receptors and sodium-calcium exchange in cardiomyopathic hamster tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The reorganization of the human and rabbit heart in response to haemodynamic overload

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Intermediate filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Cell surface receptors for extracellular matrix molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Laminin and other basement membrane components

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The cellular basis of the length-tension relation in cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The effects of muscle length on intracellular calcium transients in mammalian cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Starling's law of the heart is explained by an intimate interaction of muscle length and myofilament calcium activation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

The failing human heart is unable to use the Frank-Starling mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2898%2990063-2

7 January 2021

10.1016/S0147-9563(98)90063-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9493878%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference